Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Carr

Showing results (301-310 of 461) with videos related to

Pageof 47
Sort By:
Annals of Surgical Oncology|February 1, 2008
Treatment before liver transplantation for HCCJ Belghiti, B I Carr, P D Greig, et al.
Clinical Allergy|November 1, 1977
A study of serum antibodies to isolated milk proteins and ovalbumin in infants and childrenC D May, L Remigio, J Feldman, et al.
Cancer Research|April 1, 1986
Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene: ligand binding and autophosphorylationD L Hwang, A Roitman, B I Carr, et al.
Oncology|May 10, 2017
Role of Albumin in Growth Inhibition in Hepatocellular CarcinomaEzgi Bağırsakçı, Eren Şahin, Neşe Atabey, et al.
Journal of Gastroenterology and Hepatology|August 14, 2008
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort studyBrian I Carr, Shama C Buch, Venkateswarlu Kondragunta, et al.
Seminars in Oncology|April 1, 1997
Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysisB I Carr, A Zajko, K Bron, et al.
Hepatology Forum|March 15, 2024
Transplant and non-transplant HCC patients at a single institutionBrian I Carr, Harika Bag, Volkan Ince, et al.
Chest|December 1, 1981
Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosusT F Yeh, A Thalji, L Luken, et al.
Journal of Cellular Physiology|October 21, 2003
JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathwaysZhenggang Ren, Siddhartha Kar, Ziqiu Wang, et al.
Cancer Research|June 1, 1986
Differential interaction of normal and preneoplastic hamster bronchi with adriamycinB I Carr, D Langley, C B Dias, et al.
Pageof 47

Showing results (301-310 of 461) with videos related to

Sort By:
Pageof 47
Annals of Surgical Oncology|February 1, 2008
Treatment before liver transplantation for HCCJ Belghiti, B I Carr, P D Greig, et al.
Clinical Allergy|November 1, 1977
A study of serum antibodies to isolated milk proteins and ovalbumin in infants and childrenC D May, L Remigio, J Feldman, et al.
Cancer Research|April 1, 1986
Insulin and epidermal growth factor receptors in rat liver after administration of the hepatocarcinogen 2-acetylaminofluorene: ligand binding and autophosphorylationD L Hwang, A Roitman, B I Carr, et al.
Oncology|May 10, 2017
Role of Albumin in Growth Inhibition in Hepatocellular CarcinomaEzgi Bağırsakçı, Eren Şahin, Neşe Atabey, et al.
Journal of Gastroenterology and Hepatology|August 14, 2008
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort studyBrian I Carr, Shama C Buch, Venkateswarlu Kondragunta, et al.
Seminars in Oncology|April 1, 1997
Phase II study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysisB I Carr, A Zajko, K Bron, et al.
Hepatology Forum|March 15, 2024
Transplant and non-transplant HCC patients at a single institutionBrian I Carr, Harika Bag, Volkan Ince, et al.
Chest|December 1, 1981
Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosusT F Yeh, A Thalji, L Luken, et al.
Journal of Cellular Physiology|October 21, 2003
JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathwaysZhenggang Ren, Siddhartha Kar, Ziqiu Wang, et al.
Cancer Research|June 1, 1986
Differential interaction of normal and preneoplastic hamster bronchi with adriamycinB I Carr, D Langley, C B Dias, et al.
Pageof 47